CA2324380C - Assay for the diagnosis of schizophrenia based on a new peptide - Google Patents

Assay for the diagnosis of schizophrenia based on a new peptide Download PDF

Info

Publication number
CA2324380C
CA2324380C CA002324380A CA2324380A CA2324380C CA 2324380 C CA2324380 C CA 2324380C CA 002324380 A CA002324380 A CA 002324380A CA 2324380 A CA2324380 A CA 2324380A CA 2324380 C CA2324380 C CA 2324380C
Authority
CA
Canada
Prior art keywords
seq
peptide
sample
schizophrenia
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002324380A
Other languages
English (en)
French (fr)
Other versions
CA2324380A1 (en
Inventor
Meir Shinitzky
Michael Deckmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of CA2324380A1 publication Critical patent/CA2324380A1/en
Application granted granted Critical
Publication of CA2324380C publication Critical patent/CA2324380C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002324380A 1998-04-02 1999-03-30 Assay for the diagnosis of schizophrenia based on a new peptide Expired - Fee Related CA2324380C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12392598 1998-04-02
IL123925 1998-04-02
PCT/IL1999/000190 WO1999051725A2 (en) 1998-04-02 1999-03-30 Assay for the diagnosis of schizophrenia based on a new peptide

Publications (2)

Publication Number Publication Date
CA2324380A1 CA2324380A1 (en) 1999-10-14
CA2324380C true CA2324380C (en) 2009-02-24

Family

ID=11071395

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002324380A Expired - Fee Related CA2324380C (en) 1998-04-02 1999-03-30 Assay for the diagnosis of schizophrenia based on a new peptide

Country Status (13)

Country Link
US (1) US7098304B1 (enExample)
EP (1) EP1068303B1 (enExample)
JP (1) JP4364433B2 (enExample)
CN (1) CN1171995C (enExample)
AR (1) AR014811A1 (enExample)
AT (1) ATE309335T1 (enExample)
AU (1) AU3165599A (enExample)
BR (1) BR9909308B1 (enExample)
CA (1) CA2324380C (enExample)
DE (1) DE69928236T2 (enExample)
IL (1) IL138746A (enExample)
TW (1) TW581812B (enExample)
WO (1) WO1999051725A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002037105A1 (en) * 2000-10-31 2002-05-10 Japan As Represented By President Of Niigata University Diagnostic kit for schizophrenia
JP5048205B2 (ja) 2001-03-21 2012-10-17 イエダ リサーチ アンド デベロップメント カンパニー リミテッド 精神分裂病の診断のための新規ペプチド
CN1300588C (zh) * 2005-02-28 2007-02-14 上海交通大学 用于精神分裂症诊断的血浆特异性蛋白获取方法及应用
WO2007091881A2 (en) * 2005-04-29 2007-08-16 Leiden University Medical Center Methods and means for detection of mycobacterium leprae infections
JP2018524595A (ja) * 2015-07-14 2018-08-30 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド 統合失調症の診断で使用するためのペプチドの組み合わせ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026107A1 (en) * 1993-05-13 1994-11-24 New York University Psychosis protecting nucleic acid, peptides, compositions and method of use
US6008001A (en) * 1993-11-05 1999-12-28 Yeda Research And Development Co. Ltd. Diagnosis of the susceptibility of contracting schizophrenia
CA2184602A1 (en) * 1994-03-01 1995-09-08 Meir Shinitzky Assay for the diagnosis of schizophrenia

Also Published As

Publication number Publication date
IL138746A (en) 2006-12-10
ATE309335T1 (de) 2005-11-15
JP2002510712A (ja) 2002-04-09
CN1300320A (zh) 2001-06-20
WO1999051725A2 (en) 1999-10-14
WO1999051725A3 (en) 1999-12-02
EP1068303A2 (en) 2001-01-17
AR014811A1 (es) 2001-03-28
JP4364433B2 (ja) 2009-11-18
US7098304B1 (en) 2006-08-29
BR9909308A (pt) 2001-10-02
AU3165599A (en) 1999-10-25
HK1030966A1 (en) 2001-05-25
CA2324380A1 (en) 1999-10-14
DE69928236T2 (de) 2006-08-03
CN1171995C (zh) 2004-10-20
TW581812B (en) 2004-04-01
EP1068303B1 (en) 2005-11-09
DE69928236D1 (de) 2005-12-15
BR9909308B1 (pt) 2010-11-30

Similar Documents

Publication Publication Date Title
Chaponnier et al. The actin filament-severing domain of plasma gelsolin.
Schellekens et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
Korsching et al. Nerve growth factor in sympathetic ganglia and corresponding target organs of the rat: correlation with density of sympathetic innervation.
Jöns et al. Identification of the binding interface involved in linkage of cytoskeletal protein 4.1 to the erythrocyte anion exchanger.
McDONALD et al. Properties and distribution of the protein inhibitor (M r 17,000) of protein kinase C
CA2239208C (en) Treatment and diagnosis of infections due to helicobacter pylori
Miller et al. Antibodies directed against N-terminal residues on actin do not block acto-myosin binding
CA2324380C (en) Assay for the diagnosis of schizophrenia based on a new peptide
AU697378B2 (en) Antibiotic cryptdin peptides and methods of their use
Khanna et al. Antibodies in the sera of acute rheumatic fever patients bind to human cardiac tropomyosin
AU621943B2 (en) Determining cereal quality
WO1999038970A1 (en) Placental protein 13
HK1030966B (en) Peptide for use in the diagnosis of schizophrenia
US20110171751A1 (en) Recombinant polypeptides for diagnosing infection with trypanosoma cruzi
CA2441925C (en) Novel peptides for the diagnosis of schizophrenia
Deckmann et al. A conformational epitope which detects autoantibodies from schizophrenic patients
US6300139B1 (en) FTCD antigen
WO1991008488A1 (en) Trypsin inhibitor (alpha, at) peptide, immunoassay, monoclonal antibody and hybridoma
CA2951595A1 (en) Recombinant polypeptides for diagnosing infection with trypanosoma cruzi
EP1130030A1 (en) Human erythroid differentiation related factor
WO2006079565A2 (en) Leishmania antigens suitable for a diagnostic kit of leishmania
AU2002241232A1 (en) Novel peptides for the diagnosis of schizophrenia
van den Hoogen et al. Citrulline is an essential constituent of antigenic determinants recognizid by rheumatoid arthritis-specific autoantibodies
JP2002300882A (ja) ＢａｂｅｓｉａｇｉｂｓｏｎｉＰ５０抗原をコードする核酸分子とその発現産物の利用
EVANS et al. Purification of the renaturable protein kinase PK55 by preparative isoelectric focusing and high performance electrophoretic chromatography and the generation of PK55 monoclonal antibodies by in vitro B cell stimulation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed